Show simple item record

Política Industrial Brasileña después de 1990: Focalización sobre la Industria Farmaceutica.;
Política Industrial Brasileira pós 1990: A Indústria Farmacêutica em Questão

dc.creatorDa Silva, Christian Luiz
dc.creatorOliveira, Alexandre
dc.date2007-09-13
dc.identifierhttps://www.jotmi.org/index.php/GT/article/view/art58
dc.descriptionThe present article analyses the active principle and drug sector in Brazil after 1990. It has five sections showing that, at that time, the government priority was to maintain economic stability to the detriment of strengthening national drug industry. The article analyses the actions implemented through projects and concluded that the results of such policy were not satisfactory. Results show that the country continues to depend on multinational companies which control and progress vertical and horizontally in all stages of drug production to developing countries, thus benefiting from competitive advantages. Finally, it points out the measures needed for Brazil to join the active principle and drug international market.en-US
dc.descriptionThe present article analyses the active principle and drug sector in Brazil after 1990. It has five sections showing that, at that time, the government priority was to maintain economic stability to the detriment of strengthening national drug industry. The article analyses the actions implemented through projects and concluded that the results of such policy were not satisfactory. Results show that the country continues to depend on multinational companies which control and progress vertical and horizontally in all stages of drug production to developing countries, thus benefiting from competitive advantages. Finally, it points out the measures needed for Brazil to join the active principle and drug international market.es-ES
dc.descriptionEste artigo analisa o desenvolvimento do setor de fármacos e medicamentos, no Brasil, após 1990. Em cinco seções, mostra-se que a prioridade do governo foi a estabilidade econômica, em detrimento do fortalecimento da indústria farmacêutica nacional. Analisam-se as ações implementadas, em função dos projetos idealizados, para se chegar à conclusão de que os resultados foram insatisfatórios. Argumenta-se que o país continua dependente das empresas multinacionais que conseguem dominar, verticalizar e horizontalizar todos os estágios da produção de remédios para os países em desenvolvimento, obtendo vantagens competitivas.Finalmente, apontam-se providências necessárias para inserir o Brasil no mercado de fármacos e medicamentos internacional.pt-BR
dc.formatapplication/pdf
dc.languageeng
dc.publisherFacultad de Economía y Negocios, Universidad Alberto Hurtadoen-US
dc.relationhttps://www.jotmi.org/index.php/GT/article/view/art58/419
dc.rightsCopyright (c) 2007 Journal of Technology Management & Innovationen-US
dc.rightshttps://creativecommons.org/licenses/by-sa/4.0en-US
dc.sourceJournal of Technology Management & Innovation; Vol. 2 No. 3 (2007); 71-84en-US
dc.sourceJournal of Technology Management & Innovation; Vol. 2 Núm. 3 (2007); 71-84es-ES
dc.source0718-2724
dc.titleBrazilian Industry Policy After 1990: Focusing on the Pharmaceutical Industryen-US
dc.titlePolítica Industrial Brasileña después de 1990: Focalización sobre la Industria Farmaceutica.es-ES
dc.titlePolítica Industrial Brasileira pós 1990: A Indústria Farmacêutica em Questãopt-BR
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeArtículo revisado por paresen-US


This item appears in the following Collection(s)

Show simple item record